China Resources Double-Crane Pharmaceutical Co Ltd (600062) — Free Cash Flow Generation Index
China Resources Double-Crane Pharmaceutical Co Ltd (600062) has a Free Cash Flow Generation Index of 0.61x as of September 2025. Free cash flow of CN¥295.62 Million represents 1% of operating cash flow (CN¥487.90 Million). See 600062 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
China Resources Double-Crane Pharmaceutical Co Ltd Free Cash Flow Generation Index (1999–2024)
Historical FCF Generation Index trend for China Resources Double-Crane Pharmaceutical Co Ltd across 26 annual periods. Explore 600062 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for China Resources Double-Crane Pharmaceutical Co Ltd (1999–2024)
Year-by-year Free Cash Flow Generation Index for China Resources Double-Crane Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 600062 company net worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.65x | CN¥1.19 Billion | CN¥1.83 Billion | CN¥637.50 Million | ▲ +4.7% |
| 2023 | 0.62x | CN¥1.03 Billion | CN¥1.65 Billion | CN¥614.31 Million | ▲ +2.2% |
| 2022 | 0.61x | CN¥816.14 Million | CN¥1.34 Billion | CN¥525.53 Million | ▼ -4.0% |
| 2021 | 0.63x | CN¥849.25 Million | CN¥1.34 Billion | CN¥491.67 Million | ▼ -14.9% |
| 2020 | 0.74x | CN¥1.01 Billion | CN¥1.36 Billion | CN¥348.09 Million | ▼ -10.6% |
| 2019 | 0.83x | CN¥1.20 Billion | CN¥1.44 Billion | CN¥241.65 Million | ▼ -1.4% |
| 2018 | 0.84x | CN¥1.24 Billion | CN¥1.47 Billion | CN¥228.69 Million | ▼ -2.9% |
| 2017 | 0.87x | CN¥1.03 Billion | CN¥1.19 Billion | CN¥154.82 Million | ▲ +1.4% |
| 2016 | 0.86x | CN¥661.20 Million | CN¥771.25 Million | CN¥110.04 Million | ▲ +12.8% |
| 2015 | 0.76x | CN¥532.86 Million | CN¥701.35 Million | CN¥168.49 Million | ▼ -5.2% |
| 2014 | 0.80x | CN¥576.00 Million | CN¥718.38 Million | CN¥142.38 Million | ▲ +33.3% |
| 2013 | 0.60x | CN¥328.56 Million | CN¥546.24 Million | CN¥217.68 Million | ▲ +36.8% |
| 2012 | 0.44x | CN¥174.16 Million | CN¥396.05 Million | CN¥221.89 Million | ▲ +30.2% |
| 2011 | 0.34x | CN¥172.74 Million | CN¥511.53 Million | CN¥338.78 Million | ▲ +23.4% |
| 2010 | 0.27x | CN¥139.50 Million | CN¥509.67 Million | CN¥370.18 Million | ▲ +64.6% |
| 2009 | 0.17x | CN¥56.85 Million | CN¥342.01 Million | CN¥285.16 Million | ▲ +145.0% |
| 2008 | 0.07x | CN¥22.51 Million | CN¥331.71 Million | CN¥309.20 Million | ▼ -83.9% |
| 2007 | 0.42x | CN¥99.29 Million | CN¥235.46 Million | CN¥136.17 Million | ▼ -3.0% |
| 2006 | 0.43x | CN¥132.05 Million | CN¥303.71 Million | CN¥171.66 Million | ▲ +380.8% |
| 2005 | 0.09x | CN¥12.64 Million | CN¥139.78 Million | CN¥127.13 Million | ▼ -84.0% |
| 2004 | 0.57x | CN¥256.88 Million | CN¥453.72 Million | CN¥196.84 Million | ▲ +137.1% |
| 2003 | -1.52x | CN¥-227.05 Million | CN¥148.94 Million | CN¥375.98 Million | ▼ -92.5% |
| 2002 | -0.79x | CN¥-111.35 Million | CN¥140.63 Million | CN¥251.99 Million | ▼ -222.9% |
| 2001 | -0.25x | CN¥-34.57 Million | CN¥141.01 Million | CN¥175.58 Million | ▼ -149.3% |
| 2000 | 0.50x | CN¥85.98 Million | CN¥172.81 Million | CN¥86.83 Million | ▲ +6.1% |
| 1999 | 0.47x | CN¥61.67 Million | CN¥131.54 Million | CN¥69.86 Million | — |